Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The First Case of Kleefstra Syndrome in a Rwandan Patient with Global Developmental Delay. | Genes (Basel) | 2026 | 42074547 | PubTator, text mining | PubMed |
| The role of R-loops-mediated epigenetic regulation in genome stability maintenance and disease pathogenesis: a systematic review. | Epigenetics | 2026 | 41972847 | PubTator, text mining | PubMed |
| Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy. | Ann Med | 2026 | 41918250 | PubTator, text mining | PubMed |
Exposure-adjusted safety and efficacy of GLP-I and GLP-1/GIP receptor agonists compared with non-GLP-I for weight management and type 2 diabetes: Based on FDA medical and statistical reports of 34 280 safety and 36 312 efficacy subjects. | Br J Clin Pharmacol | 2026 | 41902330 | PubTator, text mining | PubMed |
| Mutant KRAS Heterogeneity Shapes Nuclear Architecture During Pancreatic Cancer Initiation. | Epigenomes | 2026 | 41892368 | PubTator, text mining | PubMed |
| Underutilization of syndrome-specific ICD-10 codes for genetic epilepsies: Implications for precision medicine. | Epilepsia | 2026 | 41885712 | PubTator, text mining | PubMed |
| Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine. | Hum Vaccin Immunother | 2026 | 41847975 | PubTator, text mining | PubMed |
| Safety assessment of poly(2-ethyl-2-oxazoline) for use in food contact materials. | EFSA J | 2026 | 41810090 | PubTator, text mining | PubMed |
Safety assessment of the substance (2E,2'E)-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diylbis(2-methylpropane-2,1-diyl) bis(2-cyano-3-(3,4-dimethoxyphenyl)acrylate for use in plastic food contact materials. | EFSA J | 2026 | 41800068 | PubTator, text mining | PubMed |
| From bench to bedside: the promise and roadblocks of extracellular vesicle therapeutics. | Theranostics | 2026 | 41799212 | PubTator, text mining | PubMed |
| Safety evaluation of the food enzyme endo-1,4-β-xylanase from the non-genetically modified Trichoderma citrinoviride strain TCLSC. | EFSA J | 2026 | 41768354 | PubTator, text mining | PubMed |
| Neuroendocrine-associated epigenetic factors in cellular senescence: mechanisms and therapeutic implications. | Biogerontology | 2026 | 41746442 | PubTator, text mining | PubMed |
| Safety evaluation of the food enzyme ribonuclease P from the non-genetically modified Penicillium citrinum strain AE-RPE. | EFSA J | 2026 | 41743821 | PubTator, text mining | PubMed |
| Infants exposed to maternal type 1 diabetes: intrauterine epigenetic modifications and neurological development. | Front Endocrinol (Lausanne) | 2026 | 41743545 | PubTator, text mining | PubMed |
| Differential genetic analysis of ectrodactyly in a Fanconi anemia pedigree with FANCA mutations. | MedScience | 2026 | 41733882 | PubTator, text mining | PubMed |
| Lack of genotoxicity and subchronic toxicity in safety assessment studies of a Clostridium beijerinckii formulation. | Toxicol Rep | 2026 | 41727408 | PubTator, text mining | PubMed |
| Systematic multivariate analysis of chromatin complex dependencies reveals Set1C/COMPASS as a melanoma-enriched epigenetic vulnerability. | bioRxiv | 2026 | 41726895 | PubTator, text mining | PubMed |
| Genetic-Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies. | Epigenomes | 2026 | 41718408 | PubTator, text mining | PubMed |
| Pathogenesis and intervention strategies for metabolic dysfunction-associated fatty liver disease from the perspective of the gut-microbiota-liver axis. | Front Immunol | 2026 | 41716420 | PubTator, text mining | PubMed |
| Histone 3 lysine 9 dimethylation by the G9a-GLP heterodimer requires intranucleosomal product reading. | bioRxiv | 2026 | 41648432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=2